FDA Analysis of Racial Demographics in Multiple Myeloma Trials

被引：0
|
作者：
Bhatnagar, Vishal
Gormley, Nicole
Kazandjian, Dickran
Goldberg, Kirsten
Mckee, Amy E.
Blumenthal, Gideon
Farrell, Ann T.
Pazdur, Richard
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4352
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Diversity in multiple myeloma clinical trials.
    Duma, Narjust
    Velez, Miguel Gonzalez
    Vera-Aguilera, Jesus
    Parrondo, Richardo
    Mariotti, Veronica
    Paludo, Jonas
    Wang, Yucai
    Go, Ronald
    Adjei, Alex
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (07) : 68 - 68
  • [42] CLINICAL TRIALS IN PROGRESS - LEUKAEMIA AND MULTIPLE MYELOMA
    GALTON, DAG
    [J]. PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1965, 58 (08): : 630 - &
  • [43] Evaluation of Sex, Racial and Geographic Demographics and Outcomes in Clinical Trials of Spontaneous Intracerebral Hemorrhage
    Koffman, Lauren
    Hanley, Daniel
    Anderson, Craig
    Mendelow, David
    Gregson, Barbara
    Wang, Xia
    Lane, Karen
    McBee, Nichol
    Dlugash, Rachel
    Awad, Issam
    Ziai, Wendy
    [J]. STROKE, 2017, 48
  • [44] Demographics by Sex and Race of Study Participants in Clinical Trials for Oncology Drugs Approved by the FDA in 2013
    Fadiran, Emmanuel
    Itana, Hawi
    Chen, Alice
    Pariser, Anne
    Soon, Greg
    [J]. JOURNAL OF WOMENS HEALTH, 2015, 24 (04) : 14 - 15
  • [45] Geographic and Racial Disparities in Access to Chimeric Antigen Receptor-T Cells and Bispecific Antibodies Trials for Multiple Myeloma
    Alqazaqi, Raghad
    Schinke, Carolina
    Thanendrarajan, Sharmilan
    Zangari, Maurizio
    Shaughnessy, John
    Zhan, Fenghuang
    Tricot, Guido
    van Rhee, Frits
    Al Hadidi, Samer
    [J]. JAMA NETWORK OPEN, 2022, 5 (08) : E2228877
  • [46] Enrolment of racial minorities across 15 years of multiple myeloma randomised trials; calling on researchers to become agents of change
    Mohyuddin, Ghulam Rehman
    Koehn, Kelly
    Costa, Luciano
    Kumar, Shaji K.
    McClune, Brian
    [J]. LANCET HAEMATOLOGY, 2020, 7 (10): : E704 - E706
  • [47] Analysis of Racial Differences in the Incidence of a Targetable Biomarker, t(11;14), in Patients with Multiple Myeloma
    Liu, Fang
    Kort, Jeries
    Shetty, Shashirekha
    Kyasaram, Ravikumar
    Shanahan, John
    O'Brien, Timothy E.
    [J]. BLOOD, 2020, 136
  • [48] Descriptive Analysis of Multiple Myeloma Participants in the NIH All of Us Research Program Cohort: Insights into Demographics Disparities
    Houze, T. A.
    Azuine, R. E.
    Mack, N.
    McClain, J.
    Lunt, C.
    Denny, J. C.
    [J]. CLINICAL CHEMISTRY, 2024, 70
  • [49] FDA Analysis: Impact of Body Mass Index (BMI) on Outcomes in Relapsed-Refractory Multiple Myeloma
    Ershler, Rachel
    Kanapuru, Bindu
    Gong, Yutao
    Shah, Urvi A.
    Mailankody, Sham
    Landgren, Ola
    Theoret, Marc
    Gormley, Nicole J.
    Farrell, Ann T.
    Pazdur, Richard
    [J]. BLOOD, 2019, 134
  • [50] Depth of Response in Multiple Myeloma: A Pooled Analysis of Three PETHEMA/GEM Clinical Trials
    Lahuerta, Juan-Jose
    Paiva, Bruno
    Vidriales, Maria-Belen
    Cordon, Lourdes
    Cedena, Maria-Teresa
    Puig, Noemi
    Martinez-Lopez, Joaquin
    Rosinol, Laura
    Gutierrez, Norma C.
    Martin-Ramos, Maria-Luisa
    Oriol, Albert
    Teruel, Ana-Isabel
    Echeveste, Maria-Asuncion
    de Paz, Raquel
    de Arriba, Felipe
    Hernandez, Miguel T.
    Palomera, Luis
    Martinez, Rafael
    Martin, Alejandro
    Alegre, Adrian
    De la Rubia, Javier
    Orfao, Alberto
    Mateos, Maria-Victoria
    Blade, Joan
    San-Miguel, Jesus F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (25) : 2900 - +
12345